Thailand buys 50,000 courses of Pfizer anti-viral drug Paxlovid


BANGKOK (The Nation/Asia News Network): The Medical Services Department on Thursday (March 24) signed a contract to purchase 50,000 treatment courses of Paxlovid drug with Pfizer Thailand for Covid-19 patients in risk groups.

Department director-general Somsak Akkasilp took part in the online contract signing with Deborah Seifert, country manager of Pfizer Thailand and Indochina.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , covid-19 , anti-viral , Pfizer , drug , paxlovid

Next In Aseanplus News

Turkish Red Crescent aid continues to flow into Gaza after the reopening of Rafah crossing
Philippine senator calls out China in visit to disputed island
Washington offers US$200 million to boost the American smartphone industry in Indo-Pacific
Madani govt component parties must strengthen cohesion to realise people's mandate, says Zaliha
Chinese scientists put quantum chaos in ‘slow motion’
Trump to remove Vietnam from restricted tech list, says Hanoi
Myanmar issues complete ban on e-cigarettes and e-shisha
India, Brazil sign mining pact as Modi targets $20 billion trade in five years
Muslims preserve Ramadan traditions and religious bonding all over South-East Asia, and even in Myanmar to Cambodia
US tariff ruling lifts market sentiment, positive for M'sian markets, say economists

Others Also Read